BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 1625189)

  • 1. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
    Adams JU; Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid receptor regulation in mice.
    Yoburn BC; Billings B; Duttaroy A
    J Pharmacol Exp Ther; 1993 Apr; 265(1):314-20. PubMed ID: 8386239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization and tolerance to the discriminative stimulus effects of mu-opioid agonists.
    Paronis CA; Holtzman SG
    Psychopharmacology (Berl); 1994 May; 114(4):601-10. PubMed ID: 7855222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic potency of mu and kappa opioids after systemic administration in amphibians.
    Stevens CW; Klopp AJ; Facello JA
    J Pharmacol Exp Ther; 1994 Jun; 269(3):1086-93. PubMed ID: 8014851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intrinsic efficacy on opioid tolerance.
    Duttaroy A; Yoburn BC
    Anesthesiology; 1995 May; 82(5):1226-36. PubMed ID: 7741298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.
    Stevens CW; Monasky MS; Yaksh TL
    J Pharmacol Exp Ther; 1988 Jan; 244(1):63-70. PubMed ID: 2891846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory effects of epidural and subcutaneous morphine, meperidine, fentanyl and sufentanil in the rat.
    van den Hoogen RH; Bervoets KJ; Colpaert FC
    Anesth Analg; 1988 Nov; 67(11):1071-8. PubMed ID: 2973266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
    Kest B; McLemore G; Kao B; Inturrisi CE
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.
    White DA; Holtzman SG
    J Pharmacol Exp Ther; 2005 Jul; 314(1):374-82. PubMed ID: 15843500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
    Roerig SC; Hoffman RG; Takemori AE; Wilcox GL; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1091-9. PubMed ID: 1646321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):1-8. PubMed ID: 2526212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance to morphine-like stimulus effects of mu opioid agonists.
    Young AM; Kapitsopoulos G; Makhay MM
    J Pharmacol Exp Ther; 1991 May; 257(2):795-805. PubMed ID: 2033521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial self-stimulation in rats: sensitization to an opioid antagonist following acute or chronic treatment with mu opioid agonists.
    Easterling KW; Holtzman SG
    J Pharmacol Exp Ther; 1997 Apr; 281(1):188-99. PubMed ID: 9103497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems.
    Juni A; Klein G; Kest B
    Brain Res; 2006 Jan; 1070(1):35-44. PubMed ID: 16409995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
    Ossipov MH; Harris S; Lloyd P; Messineo E
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.